Gene · 4841
Papers2,010
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,010
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications. | MedComm (2020) | 2025 | 40761481 | PubTator, text mining | PubMed |
| Trichothiodystrophy-causative pathogenic variants impair a cooperative action of TFIIH and DDX1 in R-loop processing. | Nucleic Acids Res | 2025 | 40757642 | PubTator, text mining | PubMed |
| "Molecular pigeon" network of lncRNA and miRNA: decoding metabolic reprogramming in patients with lung cancer. | Front Oncol | 2025 | 40746614 | PubTator, text mining | PubMed |
| Structural and mechanistic analysis of covalent ligands targeting the RNA-binding protein NONO. | bioRxiv | 2025 | 40661397 | PubTator, text mining | PubMed |
| NONO, SFPQ, and PSPC1 promote telomerase recruitment to the telomere. | Nat Commun | 2025 | 40593584 | PubTator, text mining | PubMed |
| Structural dynamics of IDR interactions in human SFPQ and implications for liquid-liquid phase separation. | Acta Crystallogr D Struct Biol | 2025 | 40574713 | PubTator, text mining | PubMed |
| Exosome-derived hsa_circ_0007132 promotes lenvatinib resistance by inhibiting the ubiquitin-mediated degradation of NONO. | Noncoding RNA Res | 2025 | 40521241 | PubTator, text mining | PubMed |
| Downregulation of NONO Suppresses Proliferation, Migration, and Invasion in Metastatic Prostate Cancer. | Prostate | 2025 | 40509555 | PubTator, text mining | PubMed |
| Liquid-liquid phase separation of membrane-less condensates: from biogenesis to function. | Front Cell Dev Biol | 2025 | 40438142 | PubTator, text mining | PubMed |
| Turner Syndrome Complicated by a NONO Gene Variant. | JCEM Case Rep | 2025 | 40384884 | PubTator, text mining | PubMed |
| KHSRP promotes the malignant behavior and cisplatin resistance of bladder cancer cells through the CLASP2/MAPRE1 axis. | Pharmacogenomics J | 2025 | 40382315 | PubTator, text mining | PubMed |
| Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry. | Hum Pathol | 2025 | 40381702 | PubTator, text mining | PubMed |
| Defining the transcriptional routes controlling lncRNA NEAT1 expression: implications in cellular stress response, inflammation, and differentiation. | Discov Oncol | 2025 | 40369379 | PubTator, text mining | PubMed |
| O-GlcNAcylation of NONO regulates paraspeckle component assembly and contributes to colon cancer cell proliferation. | Cell Death Discov | 2025 | 40360465 | PubTator, text mining | PubMed |
| Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor. | Genome Med | 2025 | 40340749 | PubTator, text mining | PubMed |
| Enhancer-Associated LncRNA-ITGA2 Promotes Vascular Remodeling Through ITGA2. | Circ Res | 2025 | 40321134 | PubTator, text mining | PubMed |
| Exosomal Biglycan promotes gastric cancer progression via M2 polarization and CXCL10-mediated JAK/STAT1 activation. | Cancer Lett | 2025 | 40311912 | PubTator, text mining | PubMed |
| DNMT1 is required for efficient DSB repair and maintenance of replication fork stability, and its loss reverses resistance to PARP inhibitors in cancer cells. | Oncogene | 2025 | 40234721 | PubTator, text mining | PubMed |
| TFE3 fusion oncoprotein condensates drive transcriptional reprogramming and cancer progression in translocation renal cell carcinoma. | Cell Rep | 2025 | 40222010 | PubTator, text mining | PubMed |
| Correction to: "Consensus PP1 Binding Motifs Regulate Transcriptional Corepression and Alternative RNA Splicing Activities of the Steroid Receptor Coregulators, p54nrb and PSF". | Endocrinology | 2025 | 40211934 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4841/papers?page=5